Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 7/20 | 0.61 |
| ▸ | ALOX5 | P09917 | 5/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.58 |
| ▸ | TP53 | P04637 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | TYR | P14679 | 1/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.53 |
| ▸ | ESR1 | P03372 | 2/20 | 0.50 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.50 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.50 |
| ▸ | TACR2 | P21452 | 2/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6242916 | 0.91 | TYR (0.55) | PTGS2ALOX5CYP3A4TP53MEN1 | |
| SCHEMBL13862945 | 0.88 | ALOX5 (0.59) | PTGS2ALOX5CYP3A4TP53MEN1 | |
| SCHEMBL8589832 | 0.87 | PTGS2 (0.71) | PTGS2ALOX5CYP3A4TP53MEN1 | |
| SCHEMBL127023 | 0.87 | PTGS2 (0.71) | PTGS2ALOX5CYP3A4TP53MEN1 | |
| SCHEMBL8367626 | 0.87 | PTGS2 (0.71) | PTGS2ALOX5CYP3A4TP53MEN1 | |
| SCHEMBL8588879 | 0.87 | PTGS2 (0.71) | PTGS2ALOX5CYP3A4TP53MEN1 | |
| SCHEMBL11333261 | 0.85 | PTGS2 (0.59) | PTGS2ALOX5CYP3A4TP53MEN1 | |
| SCHEMBL8971610 | 0.84 | ALOX5 (0.70) | PTGS2ALOX5CYP3A4TP53MEN1 | |
| SCHEMBL8780237 | 0.83 | PTGS2 (0.57) | PTGS2ALOX5CYP3A4TP53MEN1 | |
| SCHEMBL13862947 | 0.82 | ALOX5 (0.54) | PTGS2ALOX5CYP3A4TP53MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1917311-B1 | Rylene based multiple chromophores | BASF SE (DE) | 2015-09-23 | — | — | EP | disclosed |
| US-8501948-B2 | Multiple chromophores based on rylene | BASF AKTIENGESELLSCHAFT (DE) | 2013-08-06 | — | — | US | disclosed |
| US-20080287678-A1 | Multiple Chromophores Based on Rylene | BASF AKTIENGESELLSCHAFT (DE) | 2008-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080287678-A1 | Multiple Chromophores Based on Rylene | TDO2, PPOX, NPY1R | PTGS2 1464/4885ALOX5 406/4885CYP3A4 189/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.